当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:107.05亿  总市值:108.16亿
流通股本:9.41亿   总股本:9.50亿

派林生物(000403)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润0.23亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益810397.05万元,未分配利润244435.19万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产938271.72万元,负债127874.67万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入342,919,344.142,632,607,334.511,618,146,526.33986,481,770.22
营业总成本316,465,168.442,019,433,608.711,204,150,334.5711,561,568.4
其他经营收益
营业利润31,779,509.93527,210,376.11431,462,687.63285,726,732.32
利润总额29,076,183.34500,301,403.36406,936,999.45268,930,121.96
净利润22,731,547.4419,535,951.9357,497,339.78235,916,844.55
每股收益
其他综合收益-9,967.72-13,438.93-6,950.72-2,537.11
综合收益总额22,721,579.68419,522,512.97357,490,389.06235,914,307.44
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,550,219,651.073,721,008,187.983,775,000,285.13,320,695,525.69
非流动资产:
非流动资产合计5,832,497,555.225,745,340,888.225,800,190,956.525,760,600,597
资产总计9,382,717,206.299,466,349,076.29,575,191,241.629,081,296,122.69
流动负债:
流动负债合计1,052,647,088.671,128,483,404.021,286,570,539.25904,037,502.46
非流动负债:
非流动负债合计226,099,609.17256,616,743.41269,453,897.51279,717,896.99
负债合计1,278,746,697.841,385,100,147.431,556,024,436.761,183,755,399.45
所有者权益(或股东权益):
归属于母公司股东权益合计8,110,986,336.058,088,027,470.578,025,948,717.197,904,564,897.89
股东权益合计8,103,970,508.458,081,248,928.778,019,166,804.867,897,540,723.24
负债和股东权益合计9,382,717,206.299,466,349,076.29,575,191,241.629,081,296,122.69
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计480,097,281.632,165,748,405.961,675,909,944.71986,437,123.76
经营活动现金流出小计651,948,836.772,381,739,019.221,772,396,789.81,179,101,021.55
经营活动产生的现金流量净额-171,851,555.14-215,990,613.26-96,486,845.09-192,663,897.79
投资活动产生的现金流量:
投资活动现金流入小计316,040,553.61,552,086,245.39934,875,655.73700,121,187.61
投资活动现金流出小计443,776,304.861,783,403,421.771,510,279,572.611,038,057,408.07
投资活动产生的现金流量净额-127,735,751.26-231,317,176.38-575,403,916.88-337,936,220.46
筹资活动产生的现金流量:
筹资活动现金流入小计103,500,000771,307,747.13534,368,741.72258,151,722.36
筹资活动现金流出小计138,509,815.61874,813,259.66609,997,665.17491,747,782.81
筹资活动产生的现金流量净额-35,009,815.61-103,505,512.53-75,628,923.45-233,596,060.45
汇率变动对现金及现金等价物的影响-31,771.3849,364.89-23,583.88-8,285.78
现金及现金等价物净增加额-334,628,893.39-550,763,937.28-747,543,269.3-764,204,464.48
期末现金及现金等价物余额434,967,723.94769,596,617.33572,817,285.31556,156,090.13
补充资料:
现金及现金等价物的净增加额--550,763,937.28--764,204,464.48
最新报告期:2026-05-28
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华源证券刘闯0.400.450.512026-05-28
国投证券胡雨晴0.450.500.552026-05-02
TOP↑